Advertisement Prasco to distribute WellSpring phenoxybenzamine hydrochloride capsules in US - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Prasco to distribute WellSpring phenoxybenzamine hydrochloride capsules in US

Prasco Laboratories has signed an agreement to distribute and supply WellSpring Pharmaceutical's phenoxybenzamine hydrochloride capsules, USP of 10mg dose under the Prasco label in the US.

The AB-rated phenoxybenzamine hydrochloride capsule is the authorized generic of Dibenzyline.

Prasco chief executive officer Chris Arington said, "Patients and customers alike benefit from WellSpring’s commitment to maintaining the supply of brand-identical medication through the Prasco Authorized Generic business model."

Dibenzyline capsules are indicated for pheochromocytoma treatment to control hypertension and sweating episodes.

Concurrently, a beta-blocking agent parallel should be used in case of excessive tachycardia.

Phenoxybenzamine hydrochloride is a long-acting, adrenergic, alpha-receptor-blocking agent, which can produce and maintain "chemical sympathectomy" by oral administration.